Drugs / Meningococcal serogroup B vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00137917 | Jul 2002 → Jun 2003 | meningococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Meningococcal serogroup B vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00137917 ↗ |
| Modality | Vaccine | “outer membrane vesicle vaccine” PMID 17065257 ↗ Oct 2006 |
| Route | Intramuscular | “Given Intramuscularly” NCT00137917 ↗ |